Receptor-interacting protein 2 gene silencing attenuates allergic airway inflammation

Journal of Immunology

Volumn 191, Issue 5, 2013, Pages 2691-2699

  Goh, Fera Y ^a,b   Cook, Katrina L T P ^a,c   Upton, Nadine ^a,c   Tao, Lin ^a,b   Lah, Lin Chin ^a,b   Leung, Bernard P ^a   Fred Wong, W S ^a,b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; EOTAXIN; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 13; INTERLEUKIN 15; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 33; INTERLEUKIN 4; INTERLEUKIN 5; MESSENGER RNA; SMALL INTERFERING RNA; SYNAPTOTAGMIN I; VASCULAR CELL ADHESION MOLECULE 1;

ALLERGIC AIRWAY INFLAMMATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTHMA; CELL INFILTRATION; CONTROLLED STUDY; DNA BINDING; EOSINOPHIL COUNT; FEMALE; GENE; GENE SILENCING; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATORY CELL; LUNG LAVAGE; LYMPH NODE; MOUSE; MUCUS SECRETION; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RECEPTOR INTERACTING PROTEIN 2 GENE; RESPIRATORY TRACT ALLERGY; SIGNAL TRANSDUCTION; UPREGULATION;

ANIMALS; ASTHMA; DISEASE MODELS, ANIMAL; FEMALE; GENE SILENCING; HYPERSENSITIVITY; IMMUNOBLOTTING; MICE; MICE, INBRED BALB C; NF-KAPPA B; PNEUMONIA; RECEPTOR-INTERACTING PROTEIN SERINE-THREONINE KINASES; RESPIRATORY HYPERSENSITIVITY; RNA, SMALL INTERFERING;

EID: 84883403406     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1202416     Document Type: Article

References (54)

1. Gagliardo, R., P. Chanez, M. Mathieu, A. Bruno, G. Costanzo, C. Gougat, I. Vachier, J. Bousquet, G. Bonsignore, and A. M. Vignola. 2003. Persistent activation of nuclear factor-kappaB signaling pathway in severe uncontrolled asthma. Am. J. Respir. Crit. Care Med. 168: 1190-1198.
2. Edwards, M. R., N. W. Bartlett, D. Clarke, M. Birrell, M. Belvisi, and S. L. Johnston. 2009. Targeting the NF-kappaB pathway in asthma and chronic obstructive pulmonary disease. Pharmacol. Ther. 121: 1-13.
3. Metcalfe, D. D., R. D. Peavy, and A. M. Gilfillan. 2009. Mechanisms of mast cell signaling in anaphylaxis. J. Allergy Clin. Immunol. 124: 639-646, quiz 647-648.
4. Schulze-Luehrmann, J., and S. Ghosh. 2006. Antigen-receptor signaling to nuclear factor kB. Immunity 25: 701-715.
5. Vallabhapurapu, S., and M. Karin. 2009. Regulation and function of NF-kappaB transcription factors in the immune system. Annu. Rev. Immunol. 27: 693-733.
6. Bao, Z., S. Guan, C. Cheng, S. Wu, S. H.Wong, D. M. Kemeny, B. P. Leung, and W. S. F. Wong. 2009. A novel antiinflammatory role for andrographolide in asthma via inhibition of the nuclear factor-kappaB pathway. Am. J. Respir. Crit. Care Med. 179: 657-665.
7. Broide, D. H., T. Lawrence, T. Doherty, J. Y. Cho, M. Miller, K. McElwain, S. McElwain, and M. Karin. 2005. Allergen-induced peribronchial fibrosis and mucus production mediated by IkappaB kinase β-dependent genes in airway epithelium. Proc. Natl. Acad. Sci. USA 102: 17723-17728.
8. Das, J., C. H. Chen, L. Yang, L. Cohn, P. Ray, and A. Ray. 2001. A critical role for NF-κB in GATA3 expression and TH2 differentiation in allergic airway inflammation. Nat. Immunol. 2: 45-50.
9. Zhang, D., J. Lin, and J. Han. 2010. Receptor-interacting protein (RIP) kinase family. Cell. Mol. Immunol. 7: 243-249.
10. Kobayashi, K., N. Inohara, L. D. Hernandez, J. E. Galán, G. Núñez, C. A. Janeway, R. Medzhitov, and R. A. Flavell. 2002. RICK/Rip2/CARDIAK mediates signalling for receptors of the innate and adaptive immune systems. Nature 416: 194-199.
11. Ruefli-Brasse, A. A., W. P. Lee, S. Hurst, and V. M. Dixit. 2004. Rip2 participates in Bcl10 signaling and T-cell receptor-mediated NF-kappaB activation. J. Biol. Chem. 279: 1570-1574.
12. Yin, X., P. Krikorian, T. Logan, and V. Csizmadia. 2010. Induction of RIP-2 kinase by proinflammatory cytokines is mediated via NF-kappaB signaling pathways and involves a novel feed-forward regulatory mechanism. Mol. Cell. Biochem. 333: 251-259.
13. Krieg, A., G. Le Negrate, and J. C. Reed. 2009. RIP2-β: a novel alternative mRNA splice variant of the receptor interacting protein kinase RIP2. Mol. Immunol. 46: 1163-1170.
14. Nakashima, K., T. Hirota, Y. Suzuki, M. Akahoshi, M. Shimizu, A. Jodo, S. Doi, K. Fujita, M. Ebisawa, S. Yoshihara, et al. 2006. Association of the RIP2 gene with childhood atopic asthma. Allergol. Int. 55: 77-83.
15. de Fougerolles, A., and T. Novobrantseva. 2008. siRNA and the lung: research tool or therapeutic drug? Curr. Opin. Pharmacol. 8: 280-285.
16. Durcan, N., C. Murphy, and S. A. Cryan. 2008. Inhalable siRNA: potential as a therapeutic agent in the lungs. Mol. Pharm. 5: 559-566.
17. Duan, W., J. H. P. Chan, K. McKay, J. R. Crosby, H. H. Choo, B. P. Leung, J. G. Karras, and W. S. F. Wong. 2005. Inhaled p38a mitogen-activated protein kinase antisense oligonucleotide attenuates asthma in mice. Am. J. Respir. Crit. Care Med. 171: 571-578.
18. Goh, F. Y., N. Upton, S. Guan, C. Cheng, M. K. Shanmugam, G. Sethi, B. P. Leung, and W. S. F. Wong. 2012. Fisetin, a bioactive flavonol, attenuates allergic airway inflammation through negative regulation of NF-κB. Eur. J. Pharmacol. 679: 109-116.
19. Desmet, C., P. Gosset, B. Pajak, D. Cataldo, M. Bentires-Alj, P. Lekeux, and F. Bureau. 2004. Selective blockade of NF-κB activity in airway immune cells inhibits the effector phase of experimental asthma. J. Immunol. 173: 5766-5775.
20. Choi, I.-W., D.-K. Kim, H.-M. Ko, and H.-K. Lee. 2004. Administration of antisense phosphorothioate oligonucleotide to the p65 subunit of NF-kappaB inhibits established asthmatic reaction in mice. Int. Immunopharmacol. 4: 1817-1828.
21. Birrell, M. A., E. Hardaker, S. Wong, K. McCluskie, M. Catley, J. De Alba, R. Newton, S. Haj-Yahia, K. T. Pun, C. J. Watts, et al. 2005. Ikappa-B kinase-2 inhibitor blocks inflammation in human airway smooth muscle and a rat model of asthma. Am. J. Respir. Crit. Care Med. 172: 962-971.
22. Lu, C., A. Wang, M. Dorsch, J. Tian, K. Nagashima, A. J. Coyle, B. Jaffee, T. D. Ocain, and Y. Xu. 2005. Participation of Rip2 in lipopolysaccharide signaling is independent of its kinase activity. J. Biol. Chem. 280: 16278-16283.
23. Kersse, K., M. Lamkanfi, M. J. M. Bertrand, T. Vanden Berghe, and P. Vandenabeele. 2011. Interaction patches of procaspase-1 caspase recruitment domains (CARDs) are differently involved in procaspase-1 activation and receptorinteracting protein 2 (RIP2)-dependent nuclear factor κB signaling. J. Biol. Chem. 286: 35874-35882.
24. Moon, P.-D., I.-H. Choi, and H.-M. Kim. 2011. Naringenin suppresses the production of thymic stromal lymphopoietin through the blockade of RIP2 and caspase-1 signal cascade in mast cells. Eur. J. Pharmacol. 671: 128-132.
25. Moon, P.-D., and H.-M. Kim. 2011. Thymic stromal lymphopoietin is expressed and produced by caspase-1/NF-κB pathway in mast cells. Cytokine 54: 239-243.
26. Hasegawa, M., Y. Fujimoto, P. C. Lucas, H. Nakano, K. Fukase, G. Núñez, and N. Inohara. 2008. A critical role of RICK/RIP2 polyubiquitination in Nodinduced NF-kappaB activation. EMBO J. 27: 373-383.
27. Inohara, N., T. Koseki, J. Lin, L. del Peso, P. C. Lucas, F. F. Chen, Y. Ogura, and G. Núñez. 2000. An induced proximity model for NF-κB activation in the Nod1/RICK and RIP signaling pathways. J. Biol. Chem. 275: 27823-27831.
28. Poynter, M. E., R. Cloots, T. van Woerkom, K. J. Butnor, P. Vacek, D. J. Taatjes, C. G. Irvin, and Y. M. Janssen-Heininger. 2004. NF-κB activation in airways modulates allergic inflammation but not hyperresponsiveness. J. Immunol. 173: 7003-7009.
29. Galli, S. J., M. Tsai, and A. M. Piliponsky. 2008. The development of allergic inflammation. Nature 454: 445-454.
30. Besnard, A. G., D. Togbe, I. Couillin, Z. Tan, S. G. Zheng, F. Erard, M. Le Bert, V. Quesniaux, and B. Ryffel. 2012. Inflammasome-IL-1-Th17 response in allergic lung inflammation. J. Mol. Cell Biol. 4: 3-10.
31. Besnard, A. G., N. Guillou, J. Tschopp, F. Erard, I. Couillin, Y. Iwakura, V. Quesniaux, B. Ryffel, and D. Togbe. 2011. NLRP3 inflammasome is required in murine asthma in the absence of aluminum adjuvant. Allergy 66: 1047-1057.
32. Schmitz, J., A. Owyang, E. Oldham, Y. Song, E. Murphy, T. K. McClanahan, G. Zurawski, M. Moshrefi, J. Qin, X. Li, et al. 2005. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 23: 479-490.
33. Ziegler, S. F., and D. Artis. 2010. Sensing the outside world: TSLP regulates barrier immunity. Nat. Immunol. 11: 289-293.
34. Hogan, S. P., H. F. Rosenberg, R. Moqbel, S. Phipps, P. S. Foster, P. Lacy, A. B. Kay, and M. E. Rothenberg. 2008. Eosinophils: biological properties and role in health and disease. Clin. Exp. Allergy 38: 709-750.
35. Matsukura, S., C. Stellato, S. N. Georas, V. Casolaro, J. R. Plitt, K. Miura, S. Kurosawa, U. Schindler, and R. P. Schleimer. 2001. Interleukin-13 upregulates eotaxin expression in airway epithelial cells by a STAT6-dependent mechanism. Am. J. Respir. Cell Mol. Biol. 24: 755-761.
36. Rahman, M. S., A. Yamasaki, J. Yang, L. Shan, A. J. Halayko, and A. S. Gounni. 2006. IL-17A induces eotaxin-1/CC chemokine ligand 11 expression in human airway smooth muscle cells: role of MAPK (Erk1/2, JNK, and p38) pathways. J. Immunol. 177: 4064-4071.
37. Berry, M., C. Brightling, I. Pavord, and A. J. Wardlaw. 2007. TNF-α in asthma. Curr. Opin. Pharmacol. 7: 279-282.
38. Hot, A., V. Lenief, and P. Miossec. 2012. Combination of IL-17 and TNFα induces a pro-inflammatory, pro-coagulant and pro-thrombotic phenotype in human endothelial cells. Ann. Rheum. Dis. 71: 768-776.
39. Stolarski, B., M. Kurowska-Stolarska, P. Kewin, D. Xu, and F. Y. Liew. 2010. IL-33 exacerbates eosinophil-mediated airway inflammation. J. Immunol. 185: 3472-3480.
40. Kumar, A., Y. Takada, A. M. Boriek, and B. B. Aggarwal. 2004. Nuclear factorkappaB: its role in health and disease. J. Mol. Med. 82: 434-448.
41. Thai, P., A. Loukoianov, S. Wachi, and R. Wu. 2008. Regulation of airway mucin gene expression. Annu. Rev. Physiol. 70: 405-429.
42. Fujisawa, T., M. M. J. Chang, S. Velichko, P. Thai, L. Y. Hung, F. Huang, N. Phuong, Y. Chen, and R. Wu. 2011. NF-κB mediates IL-1β- and IL-17Ainduced MUC5B expression in airway epithelial cells. Am. J. Respir. Cell Mol. Biol. 45: 246-252.
43. Kearley, J., K. F. Buckland, S. A. Mathie, and C. M. Lloyd. 2009. Resolution of allergic inflammation and airway hyperreactivity is dependent upon disruption of the T1/ST2-IL-33 pathway. Am. J. Respir. Crit. Care Med. 179: 772-781.
44. Lane, C., D. Knight, S. Burgess, P. Franklin, F. Horak, J. Legg, A. Moeller, and S. Stick. 2004. Epithelial inducible nitric oxide synthase activity is the major determinant of nitric oxide concentration in exhaled breath. Thorax 59: 757-760.
45. Suresh, V., J. D. Mih, and S. C. George. 2007. Measurement of IL-13-induced iNOS-derived gas phase nitric oxide in human bronchial epithelial cells. Am. J. Respir. Cell Mol. Biol. 37: 97-104.
46. Jiang, J., N. Malavia, V. Suresh, and S. C. George. 2009. Nitric oxide gas phase release in human small airway epithelial cells. Respir. Res. 10: 3.
47. Wilson, R. H., G. S. Whitehead, H. Nakano, M. E. Free, J. K. Kolls, and D. N. Cook. 2009. Allergic sensitization through the airway primes Th17-dependent neutrophilia and airway hyperresponsiveness. Am. J. Respir. Crit. Care Med. 180: 720-730.
48. Kondo, Y., T. Yoshimoto, K. Yasuda, S. Futatsugi-Yumikura, M. Morimoto, N. Hayashi, T. Hoshino, J. Fujimoto, and K. Nakanishi. 2008. Administration of IL-33 induces airway hyperresponsiveness and goblet cell hyperplasia in the lungs in the absence of adaptive immune system. Int. Immunol. 20: 791-800.
49. Perkins, C., N. Yanase, G. Smulian, L. Gildea, T. Orekov, C. Potter, F. Brombacher, B. Aronow, M. Wills-Karp, and F. D. Finkelman. 2011. Selective stimulation of IL-4 receptor on smooth muscle induces airway hyperresponsiveness in mice. J. Exp. Med. 208: 853-867.
50. Elias, J. A., and C. G. Lee. 2011. IL-13 in asthma: the successful integration of lessons from mice and humans. Am. J. Respir. Crit. Care Med. 183: 957-958.
51. Pantano, C., J. L. Ather, J. F. Alcorn, M. E. Poynter, A. L. Brown, A. S. Guala, S. L. Beuschel, G. B. Allen, L. A. Whittaker, M. Bevelander, et al. 2008. Nuclear factor-kappaB activation in airway epithelium induces inflammation and hyperresponsiveness. Am. J. Respir. Crit. Care Med. 177: 959-969.
52. Meng, L., X. He, W. Zhu, X. Yang, C. Jiang, Q. Sun, S. Zhang, Q. Xue, X. Xie, and S. Lu. 2011. TLR3 and TLR7 modulate IgE production in antigen induced pulmonary inflammation via influencing IL-4 expression in immune organs. PLoS One 6: e17252.
53. Lautz, K., A. Damm, M. Menning, J. Wenger, A. C. Adam, P. Zigrino, E. Kremmer, and T. A. Kufer. 2012. NLRP10 enhances Shigella-induced proinflammatory responses. Cell. Microbiol. 14: 1568-1583.
54. Eisenbarth, S. C., A. Williams, O. R. Colegio, H. Meng, T. Strowig, A. Rongvaux, J. Henao-Mejia, C. A. Thaiss, S. Joly, D. G. Gonzalez, et al. 2012. NLRP10 is a NOD-like receptor essential to initiate adaptive immunity by dendritic cells. Nature 484: 510-513.